drugset / Trial / NCT05103410

Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy

NCT05103410

Phase 4 Completed 80 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindTreatment

Summary

The analgesic effect of perioperative use of aripiprazole has not been fully investigated. So, this study aims to test the effects of aripiprazole versus placebo in reducing postoperative pain following laparoscopic hysterectomy and to explore the potential side effects.

Timeline

Start
2021-11-10
Primary completion
2023-01-01
Completion
2023-01-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aripiprazole Other / unclassified 30 mg Oral

Indications

No indication recorded.